Clinical Phase Development Ltd in Redhill, RH1 6BF

Description

Data updated on: 01-11-2023

Registered with number 07715640 13 years ago, Clinical Phase Development Ltd is a Private Limited Company. The business actual registration address is 38 Caberfeigh Close, Redhill. The enterprise's classified under the NACE and SIC code 72110 - Research and experimental development on biotechnology. Clinical Phase Development Limited released its latest accounts for the financial year up to 2022-07-31. The business latest confirmation statement was released on 2023-07-22.

The company has one director now supervising the following company, namely Sean B. who has been doing the director's obligations for 13 years.

Sean B. is the individual who controls this firm, owns over 3/4 of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2012-07-31	2013-07-31	2014-07-31	2015-07-31	2016-07-31	2017-07-31	2018-07-31	2019-07-31	2020-07-31	2021-07-31	2022-07-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	4 265	348	304	866	985

Balance Sheet
Current Assets	12 619	11 213	4 691	2 637	2 806	2 806	1 980	13 757	8 277	23 166	37 076
Net Assets Liabilities					985	985	1 519	10 578	152	9 241	16 771
Cash Bank In Hand	12 619	11 213	4 691	2 637	2 806
Net Assets Liabilities Including Pension Asset Liability	4 265	348	304	866	985
Tangible Fixed Assets			5 880	8 347	8 347

Capital & Reserves
Called Up Share Capital	1	1	1	1	1
Profit Loss Account Reserve	4 264	347	303	865	984
Shareholder Funds	4 265	348	304	866	985

Other Financial Data
Version Production Software											2 023
Accrued Liabilities Not Expressed Within Creditors Subtotal										375	425
Creditors					10 168	10 168	10 278	10 640	13 230	16 674	19 880
Fixed Assets			5 880	8 347	8 347	8 347	9 817	7 461	5 105	2 749
Net Current Assets Liabilities	4 265	348	-5 576	-7 481	-7 362	2 806	8 298	3 117	4 953	6 492	17 196
Other Operating Expenses Format2					20 989	34 036
Profit Loss					42 759	49 336
Tax Tax Credit On Profit Or Loss On Ordinary Activities					10 168	11 318
Total Assets Less Current Liabilities	4 265	348	304	866	985	11 153	1 519	10 578	152	9 241	17 196
Turnover Revenue					73 916	94 690
Creditors Due Within One Year	8 354	10 865	10 267	10 118	10 168
Number Shares Allotted		1	1	1	1
Par Value Share		1	1	1	1
Share Capital Allotted Called Up Paid		1	1	1	1
Tangible Fixed Assets Additions			7 840	2 467
Tangible Fixed Assets Cost Or Valuation			7 840	10 307	10 307
Tangible Fixed Assets Depreciation			1 960	1 960	1 960
Tangible Fixed Assets Depreciation Charged In Period			1 960

Company staff

Sean B.

Role: Director

Appointed: 22 July 2011

Latest update: 13 April 2024

People with significant control

Sean B.

Notified on 22 July 2016

Nature of control:

over 3/4 of shares

Accounts Documents

Account next due date	30 April 2024
Account last made up date	31 July 2022
Confirmation statement next due date	05 August 2024
Confirmation statement last made up date	22 July 2023

Annual Accounts 30 October 2013
Start Date For Period Covered By Report	2012-08-01
Date Approval Accounts	30 October 2013
Annual Accounts 27 April 2015
Start Date For Period Covered By Report	2013-08-01
End Date For Period Covered By Report	2014-07-31
Date Approval Accounts	27 April 2015
Annual Accounts 26 April 2016
Start Date For Period Covered By Report	2014-08-01
End Date For Period Covered By Report	2015-07-31
Date Approval Accounts	26 April 2016
Annual Accounts 19 January 2017
Start Date For Period Covered By Report	2015-08-01
End Date For Period Covered By Report	2016-07-31
Date Approval Accounts	19 January 2017
Annual Accounts
Start Date For Period Covered By Report	01 August 2016
End Date For Period Covered By Report	31 July 2017
Annual Accounts
Start Date For Period Covered By Report	01 August 2016
End Date For Period Covered By Report	31 July 2017
Annual Accounts
Start Date For Period Covered By Report	01 August 2016
End Date For Period Covered By Report	31 July 2017
Annual Accounts
Start Date For Period Covered By Report	01 August 2016
End Date For Period Covered By Report	31 July 2017
Annual Accounts
Start Date For Period Covered By Report	01 August 2016
End Date For Period Covered By Report	31 July 2017
Annual Accounts
End Date For Period Covered By Report	2013-07-31
Annual Accounts
End Date For Period Covered By Report	31 July 2017

Clinical Phase Development Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Sean B.

People with significant control

Sean B.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies